Mylan Hit With $69.2M In Treble Damages
Blue Cross Blue Shield of Massachusetts and three other health insurance firms that opted out of a $35 million class-action settlement against Mylan Laboratories Inc. to pursue their own antitrust allegations...To view the full article, register now.
Already a subscriber? Click here to view full article